AAD 2026Abstract 73642
Roflumilast Foam 0.3% in Patients With Seborrheic Dermatitis
Subgroup Analysis of Patients With Involvement of the Face and/or Scalp in the STRATUM Trial
Ferris LK, Cook-Bolden FE, Alexis AF, Krupa D, Seal MS, Hanna D, Stephenson B, Burnett P, Gooderham MJ
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Atopic dermatitis & eczema
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.1569 · Not in PubMed: details from Crossref